HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A very unusual presentation of Niemann-Pick disease type B in an infant: similar findings to congenital lobar emphysema.

Abstract
The main features of Niemann-Pick disease type B (NPD-B) are enlargement of the liver and spleen, and mild pulmonary involvement. Recurrent respiratory tract infection and progressive decline in pulmonary function are major contributors to morbidity and mortality in this patient group. Massive pulmonary involvement in early life is extremely rare. The most common finding on chest X-rays of NPD-B patients is reticular or nodular infiltration of the lungs. This article describes a very rare presentation of NPD-B in an infant who had suffered recurrent respiratory tract infections. Massive emphysema and marked infiltrative parenchymal changes (infiltration of the parenchyma) were initially attributed to congenital lobar emphysema and its compressive effects. However, NPD was suspected when a lung biopsy showed foamy cells and sea-blue histiocytes were detected in a bone marrow biopsy. The definitive diagnosis was established with an enzyme study for sphingomyelinase.
AuthorsI S Arda, A Gençoğlu, M Coşkun, N Ozbek, B Demirhan, A Hiçsönmez
JournalEuropean journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie (Eur J Pediatr Surg) Vol. 15 Issue 4 Pg. 283-6 (Aug 2005) ISSN: 0939-7248 [Print] United States
PMID16163596 (Publication Type: Case Reports, Journal Article)
Topics
  • Diagnosis, Differential
  • Female
  • Humans
  • Infant
  • Niemann-Pick Diseases (diagnosis, pathology)
  • Pulmonary Alveoli (pathology)
  • Pulmonary Atelectasis (pathology)
  • Pulmonary Emphysema (congenital, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: